Gastric Cancer and Chemotherapy Resistance
Author Information
Author(s): He Xin, Zhong Li, Wang Nan, Zhao Baiwei, Wang Yannan, Wu Xinxiang, Zheng Changyu, Ruan Yueheng, Hou Jianfeng, Luo Yusheng, Yin Yuehan, He Yulong, Xiang Andy Peng, Wang Jiancheng
Primary Institution: The Seventh Affiliated Hospital of Sun Yat‐sen University
Hypothesis
How does the mechanical microenvironment of gastric cancer contribute to chemotherapy resistance?
Conclusion
The study found that increased matrix stiffness in gastric cancer promotes mitochondrial transfer from mesenchymal stromal cells to cancer cells, leading to chemotherapy resistance.
Supporting Evidence
- Extracellular mechanical signaling plays a crucial role in OXA resistance in gastric cancer.
- After OXA administration, GC cells actively secrete ECM to increase matrix stiffness.
- High matrix stiffness activates the RhoA/ROCK1 signaling pathway, promoting mitochondrial transfer.
- Blocking the RhoA/ROCK1 pathway alleviates OXA resistance in GC cells.
- MSCs are the main source of mitochondria transferred to GC cells.
Takeaway
Gastric cancer cells can get help from nearby cells to survive chemotherapy by taking their mitochondria, especially when the environment around them is stiff.
Methodology
The study used single-cell sequencing and in vitro and in vivo experiments to analyze mitochondrial transfer and the role of the extracellular matrix in chemotherapy resistance.
Potential Biases
Potential biases may arise from the selection of patients and the specific methodologies used in the experiments.
Limitations
The study primarily focused on a small sample size and specific patient demographics, which may limit the generalizability of the findings.
Participant Demographics
Five patients with advanced gastric cancer who underwent chemotherapy.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website